Serina Therapeutics, Inc. — Form D
Serina Therapeutics, Inc. of HUNTSVILLE, AL, a company, filed a Form D exempt-offering notice with the SEC on 2012-10-01. The offering totals $11.2M, of which $11.2M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2012-10-01
- Form: D
- Accession: 0001558525-12-000003
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $11.2M
- Amount sold: $11.2M
- Minimum investment: $40K
- Investors: 36
- Date of first sale: 2010-11-04
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-184829
Issuer
- Name: Serina Therapeutics, Inc.
- CIK: 0001558525
- Entity type: Corporation
- Jurisdiction: ALABAMA
- Address: 601 GENOME WAY, HUNTSVILLE, AL, 35806
- Phone: 2563270566
Officers, directors & promoters (15)
| Name | Role | Location |
|---|
| Lonnie S McMillian | Director | Madison, AL |
| Barbara M Fisk | Director | Harvest, AL |
| James R Hudson, Jr. | Director | Huntsville, AL |
| Randall W Moreadith | Director | Huntsville, AL |
| Randall W Moreadith | Executive Officer | Huntsville, AL |
| Steve H Ledger | Director | Mill Valley, CA |
| Greg H Bailey, M.D. | Director | Sliema, O1 |
| J Milton Harris | Director | Huntsville, AL |
| J Milton Harris | Executive Officer | Huntsville, AL |
| Tacey R Viegas | Executive Officer | Madison, AL |
| Michael D Bentley | Director | Huntsville, AL |
| Michael D Bentley | Executive Officer | Huntsville, AL |
| Miguel A Loya | Director | Houston, TX |
| Barbara Milton Fisk | Director | Madison, AL |
| Brendan A Rae | Executive Officer | Huntsville, AL |
Other filings by this issuer (15)
More